Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Digitalis glycosides. Pharmacokinetics and their clinical implications.

× No keyword cloud information.

17 in total

1. Correlation between inhibition of (Na+, K+)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig.

Authors: H Flasch; N Heinz
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1978-08 Impact factor: 3.000

Review 2. Drug treatment of fetal tachycardias.

Authors: Martijn A Oudijk; Jopje M Ruskamp; Barbara E Ambachtsheer; Tessa F F Ververs; Philip Stoutenbeek; Gerard H A Visser; Erik J Meijboom
Journal: Paediatr Drugs Date: 2002 Impact factor: 3.022

Review 3. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.

Authors: Roger W Jelliffe
Journal: Ther Drug Monit Date: 2012-08 Impact factor: 3.681

4. Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers.

Authors: P H Joubert; B N Aucamp; F O Müller
Journal: Br J Clin Pharmacol Date: 1976-12 Impact factor: 4.335

5. Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Authors: Roger W Jelliffe
Journal: Clin Pharmacokinet Date: 2016-05 Impact factor: 6.447

6. The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM Registry.

Authors: Juan Carlos Garcia-Rubira; Manuel Calvo-Taracido; Francisca Francisco-Aparicio; Manuel Almendro-Delia; Alejandro Recio-Mayoral; Antonio Reina Toral; Oscar Aramburu-Bodas; Pastora Gallego García de Vinuesa; José Maria Cruz Fernández; Angel Garcia Alcántara; Rafael Hidalgo-Urbano
Journal: Intern Emerg Med Date: 2013-12-19 Impact factor: 3.397

Digitalis glycosides. Pharmacokinetics and their clinical implications.

1. Correlation between inhibition of (Na+, K+)-membrane-ATPase and positive inotropic activity of cardenolides in isolated papillary muscles of guinea pig.

Review 2. Drug treatment of fetal tachycardias.

Review 3. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.

4. Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers.

5. Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

6. The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM Registry.

Review 7. Relation between concentrations of digoxin in the myocardium and in the plasma.

8. A standard approach to compiling clinical pharmacokinetic data.

Review 9. Digitalis pharmacokinetics and therapy with respect to impaired renal function.

10. Evaluation of digoxin concentration after loading dose in patients with renal dysfunction.